Literature DB >> 12093392

Systemic Hypertension: Management in Children and Adolescents.

Craig W. Belsha1.   

Abstract

Recognition of systemic hypertension in children and adolescents requires careful blood pressure measurement using proper technique to compare with appropriate normative data. Selected use of ambulatory blood pressure monitoring can identify children with "white coat" hypertension, thus avoiding unnecessary diagnostic testing and treatment in these children. Nonpharmacologic therapies including dietary sodium restriction, weight loss, and exercise may benefit children and adolescents with borderline hypertension and mild essential hypertension. These therapies may be important adjunctive agents in children requiring antihypertensive therapy as well. Historically, pharmacologic management of hypertension in children has been limited by a lack of controlled studies and age-appropriate formulations. Recent clinical trials have provided new information regarding a number of antihypertensive agents in this age group.

Entities:  

Year:  2002        PMID: 12093392     DOI: 10.1007/s11936-002-0015-3

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  31 in total

Review 1.  The diagnosis of renovascular disease.

Authors:  M J Dillon
Journal:  Pediatr Nephrol       Date:  1997-06       Impact factor: 3.714

2.  Intravenously administered labetalol for treatment of hypertension in children.

Authors:  T E Bunchman; R E Lynch; E G Wood
Journal:  J Pediatr       Date:  1992-01       Impact factor: 4.406

3.  Treatment of neonatal hypertension with enalaprilat.

Authors:  T G Wells; T E Bunchman; G L Kearns
Journal:  J Pediatr       Date:  1990-10       Impact factor: 4.406

Review 4.  Hypertension in children.

Authors:  A R Sinaiko
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

5.  Use of the oral angiotensin I--converting enzyme inhibitor (captopril) in childhood malignant hypertension.

Authors:  S E Oberfield; D B Case; L S Levine; R Rapaport; W Rauh; M I New
Journal:  J Pediatr       Date:  1979-10       Impact factor: 4.406

6.  Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents.

Authors: 
Journal:  Pediatrics       Date:  1996-10       Impact factor: 7.124

7.  The pharmacokinetics of enalapril in children and infants with hypertension.

Authors:  T Wells; R Rippley; R Hogg; A Sakarcan; D Blowey; P Walson; B Vogt; A Delucchi; M W Lo; E Hand; D Panebianco; W Shaw; S Shahinfar
Journal:  J Clin Pharmacol       Date:  2001-10       Impact factor: 3.126

8.  Minoxidil therapy in children with severe hypertension.

Authors:  A J Pennisi; M Takahashi; B H Bernstein; B H Singsen; C Uittenbogaart; R B Ettenger; M H Malekzadeh; V Hanson; R N Fine
Journal:  J Pediatr       Date:  1977-05       Impact factor: 4.406

9.  Nifedipine in hypertensive emergencies of children.

Authors:  U Dilmen; M K Cağlar; D A Senses; E Kinik
Journal:  Am J Dis Child       Date:  1983-12

10.  Athletic participation by children and adolescents who have systemic hypertension. American Academy of Pediatrics Committee on Sports Medicine and Fitness.

Authors: 
Journal:  Pediatrics       Date:  1997-04       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.